Zaleplon
- Product NDC
- 42043-210
- 11-digit product format
- 420430210
- Labeler code
- 42043
- Product ID
- 42043-210_3d5ebb15-7a9d-47e1-b0a7-f6d1fee80d3b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Zaleplon
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- OrchidPharma Inc
- Application
- ANDA090374
- Marketing category
- ANDA
- Marketing start
- 2018-06-20
- Marketing end
- 0000-00-00
- Substance
- ZALEPLON
- Active strength
- 5 mg/1
- Pharmacologic classes
- gamma-Aminobutyric Acid A Receptor Agonist [EPC],GABA A Agonists [MoA],Central Nervous System Depression [PE]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42043-210-01 | 42043021001 | 100 CAPSULE in 1 BOTTLE (42043-210-01) | 100 capsule | 2018-06-20 | 0000-00-00 | No | No | Current |